Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Moitessier

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|August 17, 2013
EDITORIAL: Advances in Computational Structure Based Drug DiscoveryGergely Tóth, N Moitessier
Journal of Computer-Aided Molecular Design|March 29, 2002
A comparative docking study and the design of potentially selective MMP inhibitorsS Hanessian, N Moitessier, E Therrien
Journal of Medicinal Chemistry|September 7, 2001
Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitorsS Hanessian, D B MacKay, N Moitessier
Journal of Computer-Aided Molecular Design|January 8, 1999
Elucidation of a common structure of selective fibrinogen receptor antagonistsH Minoux, N Moitessier, Y Chapleur, et al.
Journal of Medicinal Chemistry|September 7, 2001
N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pocketsS Hanessian, N Moitessier, C Gauchet, et al.
British Journal of Pharmacology|November 27, 2007
Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to goN Moitessier, P Englebienne, D Lee, et al.
Toxicology Letters|December 31, 1996
Formation of GSH-derivatives as a pathway for inactive intermediates in vinylidene chloride-treated ratsB Cossec, L Cavelier, N Moitessier-Bergé, et al.
Bioorganic & Medicinal Chemistry|March 16, 2001
Design, synthesis and preliminary biological evaluation of a focused combinatorial library of stereodiverse carbohydrate-scaffold-based peptidomimeticsN Moitessier, S Dufour, F Chrétien, et al.
Leukemia|August 31, 2016
Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activationA N McCracken, R J McMonigle, J Tessier, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|August 17, 2013
EDITORIAL: Advances in Computational Structure Based Drug DiscoveryGergely Tóth, N Moitessier
Journal of Computer-Aided Molecular Design|March 29, 2002
A comparative docking study and the design of potentially selective MMP inhibitorsS Hanessian, N Moitessier, E Therrien
Journal of Medicinal Chemistry|September 7, 2001
Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitorsS Hanessian, D B MacKay, N Moitessier
Journal of Computer-Aided Molecular Design|January 8, 1999
Elucidation of a common structure of selective fibrinogen receptor antagonistsH Minoux, N Moitessier, Y Chapleur, et al.
Journal of Medicinal Chemistry|September 7, 2001
N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pocketsS Hanessian, N Moitessier, C Gauchet, et al.
British Journal of Pharmacology|November 27, 2007
Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to goN Moitessier, P Englebienne, D Lee, et al.
Toxicology Letters|December 31, 1996
Formation of GSH-derivatives as a pathway for inactive intermediates in vinylidene chloride-treated ratsB Cossec, L Cavelier, N Moitessier-Bergé, et al.
Bioorganic & Medicinal Chemistry|March 16, 2001
Design, synthesis and preliminary biological evaluation of a focused combinatorial library of stereodiverse carbohydrate-scaffold-based peptidomimeticsN Moitessier, S Dufour, F Chrétien, et al.
Leukemia|August 31, 2016
Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activationA N McCracken, R J McMonigle, J Tessier, et al.
Pageof 1